Literature DB >> 12634341

Correlation of the rate of protein synthesis and the third power of the RNA : protein ratio in Escherichia coli and Mycobacterium tuberculosis.

Robert A Cox1.   

Abstract

In order to further understand the different physiological states of the tubercle bacillus, a frame of reference was sought by first correlating the macromolecular compositions of Escherichia coli with specific growth rates and also with the rates of protein synthesis. Data for DNA : protein : RNA were converted to the average amounts of DNA [m(DNA(av))], protein [m(p(av))] and RNA [m(RNA(av))] per cell. The specific growth rate micro was found to be directly proportional to m(RNA(av))/m(p(av)). The specific protein synthesis rate per average cell [omega(p(av))] was shown to be directly proportional to the third power of the ratio m(RNA(av))/m(p(av)) which reflects the ribosome concentration. The equations derived were shown apply to both E. coli ( micro =1.73 h(-1)) and Mycobacterium bovis BCG ( micro =0.029 h(-1)).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12634341     DOI: 10.1099/mic.0.25645-0

Source DB:  PubMed          Journal:  Microbiology        ISSN: 1350-0872            Impact factor:   2.777


  15 in total

1.  Analysis of the precursor rRNA fractions of rapidly growing mycobacteria: quantification by methods that include the use of a promoter (rrnA P1) as a novel standard.

Authors:  María Del Carmen Menéndez; María José Rebollo; María Del Carmen Núñez; Robert A Cox; María Jesús García
Journal:  J Bacteriol       Date:  2005-01       Impact factor: 3.490

2.  Compiling a molecular inventory for Mycobacterium bovis BCG at two growth rates: evidence for growth rate-mediated regulation of ribosome biosynthesis and lipid metabolism.

Authors:  D J V Beste; J Peters; T Hooper; C Avignone-Rossa; M E Bushell; J McFadden
Journal:  J Bacteriol       Date:  2005-03       Impact factor: 3.490

3.  Molecular mechanism of viomycin inhibition of peptide elongation in bacteria.

Authors:  Mikael Holm; Anneli Borg; Måns Ehrenberg; Suparna Sanyal
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-11       Impact factor: 11.205

4.  DosR-regulon genes induction in Mycobacterium bovis BCG under aerobic conditions.

Authors:  Mario Alberto Flores Valdez; Gary K Schoolnik
Journal:  Tuberculosis (Edinb)       Date:  2010-04-24       Impact factor: 3.131

5.  Deoxyribozyme cascade for visual detection of bacterial RNA.

Authors:  Yulia V Gerasimova; Evan M Cornett; Emily Edwards; Xiaoli Su; Kyle H Rohde; Dmitry M Kolpashchikov
Journal:  Chembiochem       Date:  2013-09-17       Impact factor: 3.164

6.  A broad set of different llama antibodies specific for a 16 kDa heat shock protein of Mycobacterium tuberculosis.

Authors:  Anke K Trilling; Hans de Ronde; Linda Noteboom; Adèle van Houwelingen; Margriet Roelse; Saurabh K Srivastava; Willem Haasnoot; Maarten A Jongsma; Arend Kolk; Han Zuilhof; Jules Beekwilder
Journal:  PLoS One       Date:  2011-10-26       Impact factor: 3.240

7.  Expedited quantification of mutant ribosomal RNA by binary deoxyribozyme (BiDz) sensors.

Authors:  Yulia V Gerasimova; Petro Yakovchuk; Larisa M Dedkova; Sidney M Hecht; Dmitry M Kolpashchikov
Journal:  RNA       Date:  2015-08-19       Impact factor: 4.942

8.  Appropriate DevR (DosR)-mediated signaling determines transcriptional response, hypoxic viability and virulence of Mycobacterium tuberculosis.

Authors:  Shyamasree De Majumdar; Atul Vashist; Sakshi Dhingra; Rajesh Gupta; Alka Singh; Vijay K Challu; V D Ramanathan; Prahlad Kumar; Jaya Sivaswami Tyagi
Journal:  PLoS One       Date:  2012-04-26       Impact factor: 3.240

9.  The role of GTP in transient splitting of 70S ribosomes by RRF (ribosome recycling factor) and EF-G (elongation factor G).

Authors:  Go Hirokawa; Nobuhiro Iwakura; Akira Kaji; Hideko Kaji
Journal:  Nucleic Acids Res       Date:  2008-10-23       Impact factor: 16.971

10.  In vivo evolution of a catalytic RNA couples trans-splicing to translation.

Authors:  Karen E Olson; Gregory F Dolan; Ulrich F Müller
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.